# US 2020/0390835 A1 · Composition and a method for inhibiting the growth of pathogens causing bovine liver abscesses

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0390835 A1
- Document ID: US20200390835A1
- Status: Published application
- Kind: A1
- Application number: 16/946,249
- Filed: 2020-06-12
- Published: 2020-12-17
- Earliest claimed: 2019-06-13
- Inventors: Jacques Mathieu; Pedro Alvarez
- Web page: https://patentgrep.com/patent/US20200390835A1

## CPC

- A61K 35/76: Viruses; Subviral particles; Bacteriophages
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61P 31/04: Antibacterial agents
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- C12N 2795/00021: Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2795/00032: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a composition and method for inhibiting the growth of pathogens causing liver abscesses in bovines. The composition comprises of one or more broad host-range (polyvalent) bacteriophages capable of infecting and lysing or more Fusobacterium species and an acceptable carrier for delivering said composition to said bovine. The bacteriophages are isolated and characterized for infecting and inhibiting the growth of pathogens. Particularly, the composition is orally administered daily to bovines. Moreover, the present invention relates to the method for controlling and inhibiting the growth of pathogens causing liver abscesses in bovines comprising sampling of cattle rumen; preparation of phage pools; isolation of polyvalent F. necrophorum phages; quantification of Fusobacterium species level in cattle rumen; creation of a Fusobacterium strain library; and genome sequencing of Fusobacterium species.

## Claims

### Claim 1

A composition for inhibiting the growth of pathogens causing liver abscesses in bovines comprising;
one or more bacteriophages capable of infecting and lysing one or more Fusobacterium species; and
an acceptable carrier for delivering said composition to said bovine.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the said bacteriophages are broad host-range (polyvalent).

### Claim 3 (depends on 1)

The composition of claim 1, wherein the said bacteriophages are capable of infecting and lysing said pathogens.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the said bacteriophages are isolated and characterized for infecting and inhibiting the growth of said pathogens.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the said bacteriophages are isolated with a predetermined host-range based on rumen microbial composition.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the said bacteriophages are in combination (cocktail) or a single phage species.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the said acceptable carrier comprises a material selected from the group consisting of water, a buffered solution, or feed.

### Claim 8 (depends on 1)

The composition of claim 1, wherein said composition is orally administered daily to said bovine.

### Claim 9 (depends on 1)

The composition of claim 1, wherein said composition is orally administered weekly to said bovine.

### Claim 10 (depends on 1)

The composition of claim 1, wherein said composition is orally administered monthly to said bovine.

### Claim 11 (depends on 1)

The composition of claim 1, wherein said composition is orally administered as a single dose to said bovine.

### Claim 12 (depends on 1)

The composition of claim 1, wherein said composition is orally administered in multiple doses to said bovine.

### Claim 13

A method of pathogen control for inhibiting the growth of pathogens causing liver abscesses in bovine comprising:
sampling of cattle rumen;
preparation of phage pools;
isolation of polyvalent F. necrophorum phages;
quantification of Fusobacterium species level in cattle rumen;
creation of a Fusobacterium strain library; and
genome sequencing of Fusobacterium species.

### Claim 14 (depends on 13)

The method of claim 13, wherein samples of cattle rumen are selected from unfiltered rumen fluid samples from freshly harvested cattle originating from different feedlots.

### Claim 15 (depends on 13)

The method of claim 13, wherein the said bacteriophage pools are selected from the group of environmental sources consisting of soil, fecal, rumen fluid, activated sludge, and water samples.

### Claim 16 (depends on 13)

The method of claim 13, wherein preparation of said bacteriophage pools comprises addition of elution fluids to said samples.

### Claim 17 (depends on 16)

The method of claim 16, wherein said elution fluids comprising 10 mM sodium pyrophosphate, 250 mM glycine (pH 8), SM buffer, or phosphate-buffered saline (pH 7.2) for solids, 1.0 g per 3-5 mL eluent, for slurries, an equal volume of eluant added to each sample (e.g., 3 mL to 3 mL).

### Claim 18 (depends on 13)

The method of claim 13, wherein F. necrophorum phages are isolated via prophage induction.

### Claim 19 (depends on 13)

The method of claim 13, wherein said quantification of Fusobacterium species level in cattle rumen comprises of Fusobacterium varium in abundance which is equal to at least 2×106 cells/mL.

### Claim 20 (depends on 13)

The method of claim 13, wherein the abundance of Fusobacterium species is increased by treatment with enrichment cultures in selective media containing 50 μM lactate.

### Claim 21 (depends on 13)

The method of claim 13, wherein selective isolation of Fusobacterium from rumen fluid samples is used to create said Fusobacterium strain library.
